Top 10 Best Cell And Gene Therapy Software of 2026

MasterControl stands out for its end to end document, quality, and compliance workflow coverage tailored to regulated cell and gene therapy programs. It supports electronic quality management with SOP control, change management, deviation and CAPA workflows, and audit readiness features that map to GxP expectations. It also handles batch and product lifecycle traceability by connecting quality events and approvals to the regulated records needed for submissions. Strong workflow configuration and role based review helps teams keep scientific and quality documentation synchronized across complex manufacturing and development activities.

Veeva Vault QMS stands out for its configurable, regulated quality management capabilities that fit cell and gene therapy workflows and batch-critical change control. It supports electronic quality records, controlled documentation, and audit-ready inspection trails that connect quality processes across teams. Strong configuration options enable organizations to tailor forms, approvals, and lifecycle workflows to specific manufacturing and distribution needs. Its suitability is strongest when paired with other Veeva Vault products for end-to-end quality and compliance traceability across the product lifecycle.

Benchling stands out for combining structured sample and process data with collaborative electronic lab workflows built around a configurable data model. It supports traceability across research and lab operations with sample inventories, chain-of-custody, and audit-ready recordkeeping. For cell and gene therapy work, it helps manage assays, protocols, batch context, and versioned documents tied to materials and experiments. Strong search and permissions support regulated collaboration across sites, lab teams, and cross-functional stakeholders.

Transcriptic stands out with experiment-centric automation software designed to coordinate wet-lab runs through a robotic platform. The system supports protocol execution, plate-based experiment setup, and traceable results tied to specific run configurations. It emphasizes workflow standardization with reproducible templates and audit-friendly run history, which fits cell and gene therapy research teams running high-throughput assays. The platform is strongest for experiment orchestration rather than end-to-end clinical trial operations or regulatory document management.

LabWare LIMS stands out for supporting regulated laboratory workflows with configurable processes, audit trails, and strong traceability across sample handling. It supports chromatography, ELN-linked data capture, inventory and batch-oriented records, and validation-friendly document and data control suitable for GMP environments. For cell and gene therapy programs, it fits teams that need end-to-end chain-of-custody, batch records that map to manufacturing steps, and controlled release testing documentation. It is less ideal when you only need lightweight sample tracking without validation rigor or when you require rapid out-of-the-box templates for specific C&GT workflows.

Velos eResearch stands out for its study-centric approach to research administration and operational governance in clinical and translational settings. It supports structured case processing workflows, document handling, and protocol-aligned data collection needed for complex cell and gene therapy studies. Its core strength is coordinating sponsor and site activities through configurable processes rather than offering a single-purpose wet-lab workflow tool. It is also more workflow and compliance oriented than deeply specialized for biomanufacturing execution or chain-of-identity at the equipment level.

Smartsheet stands out with spreadsheet familiarity plus enterprise-ready workflow controls for regulated operations. It supports configurable project workflows, structured reporting, and automated task execution using rules and integrations. For cell and gene therapy teams, it can manage study timelines, vendor coordination, and documentation tracking through secure sheets, forms, and approvals. Its limits show up when deeper GxP validation, full eTMF functionality, and advanced electronic QMS capabilities are required end-to-end.

AWS HealthScribe turns clinician speech into structured documentation using AWS-managed machine learning and configurable outputs. It supports generating patient notes, visit summaries, and draft documentation that can map to common clinical templates. For cell and gene therapy programs, it can capture trial visit narratives and collection events from real-time conversations for later review. Its strongest value comes from reducing manual transcription and drafting time while keeping clinicians in control of final content.

Databricks stands out for combining a unified data platform with scalable Spark-based processing for complex genomic and phenotypic workflows. For cell and gene therapy use cases, it supports ingestion, transformation, and feature-ready analytics across large imaging, omics, and assay datasets using notebooks, SQL, and ML tooling. It also enables governed collaboration through workspace controls, lineage-friendly data engineering patterns, and integration with external systems for lab and clinical data flows.

OpenClinica stands out as an open-source clinical data management system tailored to regulated study execution. It supports structured case report forms, audit trails, and data review workflows needed for clinical operations in cell and gene therapy programs. The platform integrates data validation and query management to help coordinators reconcile center-entered data against protocol expectations. Its strength is managing complex study data lifecycles, while customization and administration can demand technical resources.